Patents by Inventor Catherine A. Spargo

Catherine A. Spargo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7344884
    Abstract: The present invention provides specific peptides identified as having cell adhesion, growth, expression or secretion-enhancing activities. Many of the peptides of the invention may be produced in large quantity by such means as chemical synthesis or recombinant DNA methodology. They may be non-specifically adsorbed, or chemically attached to a surface or, alternatively, formulated in a culture medium to produce the desired effect on cultured cells.
    Type: Grant
    Filed: February 9, 2006
    Date of Patent: March 18, 2008
    Assignee: Becton, Dickinson and Company
    Inventors: Robert L. Campbell, Mohammad Heidaran, Catherine A. Spargo, Jamie H. Wilkins, Perry D. Haaland
  • Publication number: 20060241055
    Abstract: The present invention provides specific peptides identified as having cell adhesion, growth, expression or secretion-enhancing activities. Many of the peptides of the invention may be produced in large quantity by such means as chemical synthesis or recombinant DNA methodology. They may be non-specifically adsorbed, or chemically attached to a surface or, alternatively, formulated in a culture medium to produce the desired effect on cultured cells.
    Type: Application
    Filed: February 9, 2006
    Publication date: October 26, 2006
    Applicant: Becton Dickinson and Company
    Inventors: Robert Campbell, Mohammad Heidaran, Catherine Spargo, Jamie Wilkins, Perry Haaland
  • Publication number: 20060110754
    Abstract: Described and disclosed are devices, methods, and compositions of matter for the multiplex amplification and analysis of nucleic acid sequences in a sample using novel strand displacement amplification technologies in combination with bioelectronic microchip technology. Specifically, a nucleic acid in a sample is amplified to form amplicons, the amplicons are addressed to specified electronically addressable capture sites of the bioelectronic microchip, the addressed amplicons are captured and labeled, and then the capture sites are analyzed for the presence of label. Samples may be amplified using strand displacement amplification. The invention is also amenable to other amplification methodologies well known by those skilled in the art. The capture and label steps may be by a method of universal capture with sequence specific reporter, or by a method of sequence specific capture with universal reporter.
    Type: Application
    Filed: October 14, 2005
    Publication date: May 25, 2006
    Inventors: Michael Nerenberg, Carl Edman, Catherine Spargo, George Walker
  • Patent number: 7041506
    Abstract: The present invention provides specific peptides identified as having cell adhesion, growth, expression or secretion-enhancing activities. Many of the peptides of the invention may be produced in large quantity by such means as chemical synthesis or recombinant DNA methodology. They may be non-specifically adsorbed, or chemically attached to a surface or, alternatively, formulated in a culture medium to produce the desired effect on cultured cells.
    Type: Grant
    Filed: November 19, 2001
    Date of Patent: May 9, 2006
    Assignee: Becton Dickinson and Company
    Inventors: Robert L. Campbell, Mohammad Heidaran, Catherine A. Spargo, Jamie H. Wilkins, Perry Haaland
  • Patent number: 6967086
    Abstract: The invention provides a method and apparatus for determining the presence or absence of respiring cells, involving combining a three-dimensional biomimetic scaffold and cells onto a sensor composition.
    Type: Grant
    Filed: March 28, 2002
    Date of Patent: November 22, 2005
    Assignee: Becton Dickinson and Company
    Inventors: Richard David Guarino, John Jacob Hemperly, Catherine A. Spargo, Andrea Liebmann-Vinson, Mohammad A. Heidaran
  • Publication number: 20030175745
    Abstract: Peptides and peptide compositions are identified which inhibit the growth of abnormal cells. In one embodiment, the peptides are useful for inhibiting the growth of cells dependent on autocrine activation of the PDGF receptor. Such peptides may be used in the treatment of cell proliferative disorders including cancer, fibrotic disorders, myeloproliferative diseases and blood vessel proliferative (angiogenic) disorders characterized by inappropriate PDGF receptor activity. A biomedical device is further disclosed which has associated with it a peptide or peptide composition according to the present invention.
    Type: Application
    Filed: September 30, 2002
    Publication date: September 18, 2003
    Inventors: Cheryl H. Dean, Mohammad A. Heidaran, Catherine A. Spargo, Perry D. Haaland
  • Publication number: 20030162289
    Abstract: The present invention provides specific peptides identified as having cell adhesion, growth, expression or secretion-enhancing activities. Many of the peptides of the invention may be produced in large quantity by such means as chemical synthesis or recombinant DNA methodology. They may be non-specifically adsorbed, or chemically attached to a surface or, alternatively, formulated in a culture medium to produce the desired effect on cultured cells.
    Type: Application
    Filed: November 19, 2001
    Publication date: August 28, 2003
    Inventors: Robert L. Campbell, Mohammad Heidaran, Catherine A. Spargo, Jamie H. Wilkins, Perry Haaland
  • Publication number: 20030104430
    Abstract: Described and disclosed are devices, methods, and compositions of matter for the multiplex amplification and analysis of nucleic acid sequences in a sample using novel strand displacement amplification technologies in combination with bioelectronic microchip technology. Specifically, a nucleic acid in a sample is amplified to form amplicons, the amplicons are addressed to specified electronically addressable capture sites of the bioelectronic microchip, the addressed amplicons are captured and labeled, and then the capture sites are analyzed for the presence of label. Samples may be amplified using strand displacement amplification. The invention is also amenable to other amplification methodologies well known by those skilled in the art. The capture and label steps may be by a method of universal capture with sequence specific reporter, or by a method of sequence specific capture with universal reporter.
    Type: Application
    Filed: July 15, 2002
    Publication date: June 5, 2003
    Inventors: Michael I. Nerenberg, Carl F. Edman, Catherine A. Spargo, George Terrance Walker
  • Publication number: 20020192636
    Abstract: The present invention relates to cell culture. In particular, this invention is directed to methods and apparatuses used to observe or quantitate cell proliferation in the presence of potential growth promoting molecules in a two or three dimensional architecture.
    Type: Application
    Filed: March 28, 2002
    Publication date: December 19, 2002
    Inventors: Richard David Guarino, John Jacob Hemperly, Catherine A. Spargo, Andrea Liebmann-Vinson, Mohammad A. Heidaran
  • Patent number: 6066458
    Abstract: Methods for determining quantities of nucleic acid sequences in samples undergoing amplification utilize amplification ratio estimates (R*) in operations to accurately perform absolute quantitation even when amplification factors for the target and control sequences undergoing amplification are different, time dependent or vary as a function of starting concentrations of nucleic acid sequences. These operations also take into account conversion efficiencies associated with the conversion of probes upon generation of target or control amplicons, but do not require the explicit calculation of such efficiencies. The operations also recognize that a preferred R* should be determined based on a preferred statistical criterion to improve quantitation. In addition, the use of standard samples having known starting concentrations of target and control sequences therein may enable accurate absolute quantitation without the explicit calculation of amplification ratio estimates.
    Type: Grant
    Filed: May 18, 1998
    Date of Patent: May 23, 2000
    Assignee: Becton, Dickinson and Company
    Inventors: Perry D. Haaland, James G. Nadeau, Colleen M. Nycz, Cheryl H. Dean, Catherine A. Spargo
  • Patent number: 5744311
    Abstract: Strand Displacement Amplification methods (thermophilic SDA) which can be performed over a broad temperature range (37.degree. C. to 70.degree. C.). The preferred temperature range for thermophilic SDA is 50.degree. C. to 70.degree. C. It has been found that certain thermophilic restriction endonucleases are capable of nicking the hemimodified restriction endonuclease recognition/cleavage site as required by SDA and dissociating from the site. It has further been found that certain thermophilic polymerases are capable of extending from the nick while displacing the downstream strand. Thermophilic SDA, because of reaction temperatures higher than previously possible with conventional SDA enzyme systems, has improved specificity and efficiency, reduced nonspecific background amplification, and potentially improved yields of amplification products.
    Type: Grant
    Filed: August 22, 1996
    Date of Patent: April 28, 1998
    Assignee: Becton, Dickinson and Company
    Inventors: Melinda S. Fraiser, Catherine A. Spargo, George Terrance Walker, Mark Van Cleve, David James Wright, Michael C. Little
  • Patent number: 5648211
    Abstract: Strand Displacement Amplification methods (thermophilic SDA) which can be performed over a broad temperature range (37.degree. C. to 70.degree. C.). The preferred temperature range for thermophilic SDA is 50.degree. C. to 70.degree. C. It has been found that certain thermophilic restriction endonucleases are capable of nicking the hemimodified restriction endonuclease recognition/cleavage site as required by SDA and dissociating from the site. It has further been found that certain thermophilic polymerases are capable of extending from the nick while displacing the downstream strand. Thermophilic SDA, because of reaction temperatures higher than previously possible with conventional SDA enzyme systems, has improved specificity and efficiency, reduced nonspecific background amplification, and potentially improved yields of amplification products.
    Type: Grant
    Filed: April 18, 1994
    Date of Patent: July 15, 1997
    Assignee: Becton, Dickinson and Company
    Inventors: Melinda S. Fraiser, Catherine A. Spargo, George Terrance Walker, Mark Van Cleve, David James Wright, Michael C. Little